The mental health market is experiencing significant growth globally, driven by factors such as increasing awareness, rising prevalence of mental disorders, and advancements in treatment options. This overview will provide insights into the mental health markets across six regions: Asia-Pacific, Europe, North America, Latin America, Middle East and Africa (MEA), and Rest of World (ROW)....

Market Overview – The Heart Failure Point of Care (POC) and Lab-on-a-Chip (LOC) devices market is witnessing significant growth, driven by advancements in healthcare technology and the rising prevalence of heart failure worldwide. These devices play a crucial role in diagnosing and monitoring heart failure, offering convenient and rapid testing solutions for both healthcare professionals...

Market Overview In 2022, the cellulite treatment market size was estimated at USD 0.5 billion. The cellulite treatment market is expected to increase from USD 0.554 billion in 2023 to USD 1.268 billion by 2032, with a compound annual growth rate (CAGR) of 10.90% over the forecast period (2023-2032). Growth Drivers and Deterrents Cellulite formation is caused by uneven distribution of muscle,...

Market Overview – The market for epilepsy devices was estimated to be worth USD 1.3 billion in 2021 and is expected to increase to USD 2.6 billion by 2030, with a compound annual growth rate (CAGR) of 9.20% from USD 1.4 billion in 2022 to USD 2.6 billion in 2030. The epilepsy devices market focuses on medical devices and technologies designed to manage and treat epilepsy, a neurological...

Market Overview – Aptamers market size is expected to reach USD 2.3 billion by 2022. The Aptamers market industry is expected to increase from USD 2.74 billion in 2023 to USD 11.42 billion in 2032, with a compound annual growth rate (CAGR) of 19.50% during the forecast period (2023-2032). The Aptamers Market is expanding rapidly, driven by the increasing interest in aptamer therapeutics...

Market Overview – The market for fetal bovine serum was estimated to be worth USD 0.9 billion in 2022 and is expected to increase to USD 1.5 billion by 2030, with a compound annual growth rate (CAGR) of 5.7% from USD 0.95 billion in 2023 to USD 1.5 billion in 2023. The fetal bovine serum (FBS) market involves the production, distribution, and sale of serum derived from the blood of fetal...

Market Overview – The ADME Toxicology Testing Market is growing with the rising demand for efficient drug development and safety assessment processes. ADME and Toxicology testing (Absorption, Distribution, Metabolism, and Excretion), evaluate a drug's pharmacokinetics and potential toxicity. The market offers a range of assays, technologies, and services to support drug discovery and...

Market Overview – Over the projected period of 2022–2030, the US melanoma market is expected to grow at a 10.8% CAGR to reach USD 5.73 billion by 2030. The Melanoma Market is evolving with advancements in detection and treatment options for cancerous moles. Rising awareness of skin cancer risks fuels early detection efforts, driving demand for innovative therapies. With ongoing...

Market Overview – Over the forecast period, the osteoporosis medications market is expected to develop at a compound annual growth rate (CAGR) of 3.5%, reaching a value of $12.8 billion. The osteoporosis drugs market focuses on pharmaceutical products aimed at preventing and treating osteoporosis, a bone disease characterized by low bone density and increased risk of fractures....

Market Overview – In 2022, the healthcare biometrics market was estimated to be worth USD 19.2 billion. The healthcare biometrics market is expected to expand at a compound annual growth rate (CAGR) of 22.1% between 2023 and 2032, from an estimated USD 23.4816 billion in 2023 to USD 79.2 billion by 2032. The healthcare biometrics market, leveraging biometric medical solutions, is...